Intralesional bleomycin for the management of recalcitrant periungual warts

Ungual warts are very common benign growths in the dermatological outpatient department that are often tough to treat as they are resistant to available treatments and frequently recur. A variety of therapeutic modalities have been used with varying degrees of success. Intralesional bleomycin has emerged as an effective treatment option for recalcitrant periungual warts with minimal side effects. We report the case of a 22-year-old male with recalcitrant ungual warts which responded dramatically to intralesional bleomycin.